Advertisement

Index by Author

January 1986; 35 (1)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ackermann, K E

    • Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes January 1986 35:20-27; doi:10.2337/diabetes.35.1.20

  2. Albisser, A M

    • Metabolic control in diabetic dogs treated with pancreatic autotransplants and insulin pumps. Diabetes January 1986 35:97-100; doi:10.2337/diabetes.35.1.97

  3. Alwmark, A

    • Calcitonin inhibition of insulin release from isolated rat pancreatic islets. Diabetes January 1986 35:58-60; doi:10.2337/diabetes.35.1.58

  4. Ammon, H P

    • Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes January 1986 35:38-43; doi:10.2337/diabetes.35.1.38

  5. Avraham, H

    • A human monoclonal antibody to insulin. Diabetes January 1986 35:68-73; doi:10.2337/diabetes.35.1.68

B

  1. Bedoya, F J

    • The glucokinase glucose sensor in human pancreatic islet tissue. Diabetes January 1986 35:61-67; doi:10.2337/diabetes.35.1.61

  2. Bellgrau, D

    • Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat. Diabetes January 1986 35:110-114; doi:10.2337/diabetes.35.1.110

  3. Berger, R A

    • Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes January 1986 35:20-27; doi:10.2337/diabetes.35.1.20

  4. Boden, G

    • Effects of anti-insulin receptor antibodies (AIRA) on downregulation and turnover of insulin receptors on cultured hepatocytes. Diabetes January 1986 35:28-32; doi:10.2337/diabetes.35.1.28

  5. Bogardus, C

    • Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes January 1986 35:1-5; doi:10.2337/diabetes.35.1.1

  6. Bucy, R P

    • The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts. Diabetes January 1986 35:83-88; doi:10.2337/diabetes.35.1.83

C

  1. Cabello, M A

    • Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes January 1986 35:89-96; doi:10.2337/diabetes.35.1.89

  2. Chang, K

    • Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes January 1986 35:20-27; doi:10.2337/diabetes.35.1.20

  3. Cohen, I R

    • A human monoclonal antibody to insulin. Diabetes January 1986 35:68-73; doi:10.2337/diabetes.35.1.68

  4. Cooper, C W

    • Calcitonin inhibition of insulin release from isolated rat pancreatic islets. Diabetes January 1986 35:58-60; doi:10.2337/diabetes.35.1.58

D

  1. Davie, J M

    • The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts. Diabetes January 1986 35:83-88; doi:10.2337/diabetes.35.1.83

E

  1. Elias, D

    • A human monoclonal antibody to insulin. Diabetes January 1986 35:68-73; doi:10.2337/diabetes.35.1.68

  2. Eshhar, Z

    • A human monoclonal antibody to insulin. Diabetes January 1986 35:68-73; doi:10.2337/diabetes.35.1.68

  3. Esmann, J

    • Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas. Diabetes January 1986 35:119-123; doi:10.2337/diabetes.35.1.119

F

  1. Fairtile, R

    • Opioid peptides in rat islets of Langerhans. Immunoreactive met- and leu-enkephalins and BAM-22P. Diabetes January 1986 35:52-57; doi:10.2337/diabetes.35.1.52

  2. Feliu, J E

    • Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes January 1986 35:89-96; doi:10.2337/diabetes.35.1.89

  3. Finegold, D

    • The glucokinase glucose sensor in human pancreatic islet tissue. Diabetes January 1986 35:61-67; doi:10.2337/diabetes.35.1.61

G

  1. Gerich, J E

    • Familial insulin resistance and acanthosis nigricans. Presence of a postbinding defect. Diabetes January 1986 35:33-37; doi:10.2337/diabetes.35.1.33

  2. Ghosh, A K

    • The glucokinase glucose sensor in human pancreatic islet tissue. Diabetes January 1986 35:61-67; doi:10.2337/diabetes.35.1.61

  3. Gishizky, M L

    • Effects of tolbutamide pretreatment on the rate of conversion of newly synthesized proinsulin to insulin and the compartmental characteristics of insulin storage in isolated rat islets. Diabetes January 1986 35:6-12; doi:10.2337/diabetes.35.1.6

  4. Goldfine, I D

    • Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes January 1986 35:38-43; doi:10.2337/diabetes.35.1.38

  5. Gold, G

    • Effects of tolbutamide pretreatment on the rate of conversion of newly synthesized proinsulin to insulin and the compartmental characteristics of insulin storage in isolated rat islets. Diabetes January 1986 35:6-12; doi:10.2337/diabetes.35.1.6

  6. Greeley, G H, Jr

    • Calcitonin inhibition of insulin release from isolated rat pancreatic islets. Diabetes January 1986 35:58-60; doi:10.2337/diabetes.35.1.58

  7. Greenberg, G R

    • Metabolic control in diabetic dogs treated with pancreatic autotransplants and insulin pumps. Diabetes January 1986 35:97-100; doi:10.2337/diabetes.35.1.97

  8. Grill, V

    • Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands. Diabetes January 1986 35:44-51; doi:10.2337/diabetes.35.1.44

  9. Grodsky, G M

    • Effects of tolbutamide pretreatment on the rate of conversion of newly synthesized proinsulin to insulin and the compartmental characteristics of insulin storage in isolated rat islets. Diabetes January 1986 35:6-12; doi:10.2337/diabetes.35.1.6

H

  1. Haneda, M

    • Low frequency of the large insertion in the human insulin gene in Japanese. Diabetes January 1986 35:115-118; doi:10.2337/diabetes.35.1.115

  2. Harrison, L C

    • Structure of the human erythrocyte insulin receptor. Diabetes January 1986 35:101-105; doi:10.2337/diabetes.35.1.101

  3. Hauptfeld, V

    • The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts. Diabetes January 1986 35:83-88; doi:10.2337/diabetes.35.1.83

  4. Hayles, A B

    • Familial insulin resistance and acanthosis nigricans. Presence of a postbinding defect. Diabetes January 1986 35:33-37; doi:10.2337/diabetes.35.1.33

  5. Haymond, M W

    • Familial insulin resistance and acanthosis nigricans. Presence of a postbinding defect. Diabetes January 1986 35:33-37; doi:10.2337/diabetes.35.1.33

  6. Helve, E

    • Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII. Diabetes January 1986 35:78-82; doi:10.2337/diabetes.35.1.78

  7. Hermansen, K

    • Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas. Diabetes January 1986 35:119-123; doi:10.2337/diabetes.35.1.119

  8. Howard, B V

    • Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes January 1986 35:1-5; doi:10.2337/diabetes.35.1.1

K

  1. Kappelgaard, A M

    • Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas. Diabetes January 1986 35:119-123; doi:10.2337/diabetes.35.1.119

  2. Karonen, S L

    • Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII. Diabetes January 1986 35:78-82; doi:10.2337/diabetes.35.1.78

  3. Kaung, H L

    • An immunohistochemical, ultrastructural, and physiologic study of pancreatic islets from copper-deficient, penicillamine-treated rats. Diabetes January 1986 35:13-19; doi:10.2337/diabetes.35.1.13

  4. Kawada, J

    • New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells. Diabetes January 1986 35:74-77; doi:10.2337/diabetes.35.1.74

  5. Kilo, C

    • Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes January 1986 35:20-27; doi:10.2337/diabetes.35.1.20

  6. King, C

    • Opioid peptides in rat islets of Langerhans. Immunoreactive met- and leu-enkephalins and BAM-22P. Diabetes January 1986 35:52-57; doi:10.2337/diabetes.35.1.52

  7. Kobayashi, M

    • Low frequency of the large insertion in the human insulin gene in Japanese. Diabetes January 1986 35:115-118; doi:10.2337/diabetes.35.1.115

  8. Koivisto, V A

    • Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII. Diabetes January 1986 35:78-82; doi:10.2337/diabetes.35.1.78

L

  1. Lacy, P E

    • The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts. Diabetes January 1986 35:83-88; doi:10.2337/diabetes.35.1.83

  2. Lafferty, K J

    • Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat. Diabetes January 1986 35:110-114; doi:10.2337/diabetes.35.1.110

  3. Landahl, H D

    • Effects of tolbutamide pretreatment on the rate of conversion of newly synthesized proinsulin to insulin and the compartmental characteristics of insulin storage in isolated rat islets. Diabetes January 1986 35:6-12; doi:10.2337/diabetes.35.1.6

  4. Leone, J P

    • Immunochemical studies of an insulin-like material in the parotid gland of diabetic BB rats. Diabetes January 1986 35:106-109; doi:10.2337/diabetes.35.1.106

  5. Lillioja, S

    • Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes January 1986 35:1-5; doi:10.2337/diabetes.35.1.1

  6. Livneh, A

    • A human monoclonal antibody to insulin. Diabetes January 1986 35:68-73; doi:10.2337/diabetes.35.1.68

M

  1. Maegawa, H

    • Low frequency of the large insertion in the human insulin gene in Japanese. Diabetes January 1986 35:115-118; doi:10.2337/diabetes.35.1.115

  2. Mandarino, L J

    • Familial insulin resistance and acanthosis nigricans. Presence of a postbinding defect. Diabetes January 1986 35:33-37; doi:10.2337/diabetes.35.1.33

  3. Marvel, J

    • Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes January 1986 35:20-27; doi:10.2337/diabetes.35.1.20

  4. Matschinsky, F M

    • The glucokinase glucose sensor in human pancreatic islet tissue. Diabetes January 1986 35:61-67; doi:10.2337/diabetes.35.1.61

  5. McPhedran, N T

    • Metabolic control in diabetic dogs treated with pancreatic autotransplants and insulin pumps. Diabetes January 1986 35:97-100; doi:10.2337/diabetes.35.1.97

  6. Mojena, M

    • Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes January 1986 35:89-96; doi:10.2337/diabetes.35.1.89

  7. Monge, L

    • Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes January 1986 35:89-96; doi:10.2337/diabetes.35.1.89

  8. Mott, D

    • Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes January 1986 35:1-5; doi:10.2337/diabetes.35.1.1

N

  1. Nishida, M

    • New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells. Diabetes January 1986 35:74-77; doi:10.2337/diabetes.35.1.74

  2. Nomura, M

    • Metabolic control in diabetic dogs treated with pancreatic autotransplants and insulin pumps. Diabetes January 1986 35:97-100; doi:10.2337/diabetes.35.1.97

O

  1. Orskov, H

    • Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas. Diabetes January 1986 35:119-123; doi:10.2337/diabetes.35.1.119

  2. Ortega, J L

    • Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes January 1986 35:89-96; doi:10.2337/diabetes.35.1.89

P

  1. Pelkonen, R

    • Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII. Diabetes January 1986 35:78-82; doi:10.2337/diabetes.35.1.78

  2. Pou, J

    • Effects of tolbutamide pretreatment on the rate of conversion of newly synthesized proinsulin to insulin and the compartmental characteristics of insulin storage in isolated rat islets. Diabetes January 1986 35:6-12; doi:10.2337/diabetes.35.1.6

  3. Prowse, S J

    • Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat. Diabetes January 1986 35:110-114; doi:10.2337/diabetes.35.1.110

R

  1. Recant, L

    • Opioid peptides in rat islets of Langerhans. Immunoreactive met- and leu-enkephalins and BAM-22P. Diabetes January 1986 35:52-57; doi:10.2337/diabetes.35.1.52

  2. Rizza, R A

    • Familial insulin resistance and acanthosis nigricans. Presence of a postbinding defect. Diabetes January 1986 35:33-37; doi:10.2337/diabetes.35.1.33

  3. Rowold, E

    • Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes January 1986 35:20-27; doi:10.2337/diabetes.35.1.20

  4. Rundfeldt, M

    • Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands. Diabetes January 1986 35:44-51; doi:10.2337/diabetes.35.1.44

S

  1. Sack, J

    • A human monoclonal antibody to insulin. Diabetes January 1986 35:68-73; doi:10.2337/diabetes.35.1.68

  2. Samper, B

    • Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes January 1986 35:89-96; doi:10.2337/diabetes.35.1.89

  3. Savage, C R, Jr

    • Effects of anti-insulin receptor antibodies (AIRA) on downregulation and turnover of insulin receptors on cultured hepatocytes. Diabetes January 1986 35:28-32; doi:10.2337/diabetes.35.1.28

  4. Schwenk, W F

    • Familial insulin resistance and acanthosis nigricans. Presence of a postbinding defect. Diabetes January 1986 35:33-37; doi:10.2337/diabetes.35.1.33

  5. Shelmet, J J

    • Effects of anti-insulin receptor antibodies (AIRA) on downregulation and turnover of insulin receptors on cultured hepatocytes. Diabetes January 1986 35:28-32; doi:10.2337/diabetes.35.1.28

  6. Sherman, W R

    • Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes January 1986 35:20-27; doi:10.2337/diabetes.35.1.20

  7. Shigeta, Y

    • Low frequency of the large insertion in the human insulin gene in Japanese. Diabetes January 1986 35:115-118; doi:10.2337/diabetes.35.1.115

  8. Shimoyama, R

    • Effects of anti-insulin receptor antibodies (AIRA) on downregulation and turnover of insulin receptors on cultured hepatocytes. Diabetes January 1986 35:28-32; doi:10.2337/diabetes.35.1.28

  9. Smith, P H

    • Immunochemical studies of an insulin-like material in the parotid gland of diabetic BB rats. Diabetes January 1986 35:106-109; doi:10.2337/diabetes.35.1.106

  10. Sorenson, R L

    • An immunohistochemical, ultrastructural, and physiologic study of pancreatic islets from copper-deficient, penicillamine-treated rats. Diabetes January 1986 35:13-19; doi:10.2337/diabetes.35.1.13

  11. Stavinoha, M W

    • Calcitonin inhibition of insulin release from isolated rat pancreatic islets. Diabetes January 1986 35:58-60; doi:10.2337/diabetes.35.1.58

  12. Stearns, S B

    • Immunochemical studies of an insulin-like material in the parotid gland of diabetic BB rats. Diabetes January 1986 35:106-109; doi:10.2337/diabetes.35.1.106

T

  1. Taskinen, M R

    • Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes January 1986 35:1-5; doi:10.2337/diabetes.35.1.1

  2. Terasaka, R

    • The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts. Diabetes January 1986 35:83-88; doi:10.2337/diabetes.35.1.83

  3. Thompson, J C

    • Calcitonin inhibition of insulin release from isolated rat pancreatic islets. Diabetes January 1986 35:58-60; doi:10.2337/diabetes.35.1.58

  4. Timmers, K I

    • Opioid peptides in rat islets of Langerhans. Immunoreactive met- and leu-enkephalins and BAM-22P. Diabetes January 1986 35:52-57; doi:10.2337/diabetes.35.1.52

  5. Toide, K

    • New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells. Diabetes January 1986 35:74-77; doi:10.2337/diabetes.35.1.74

  6. Tomlinson, M

    • Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes January 1986 35:20-27; doi:10.2337/diabetes.35.1.20

  7. Tsujihara, K

    • New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells. Diabetes January 1986 35:74-77; doi:10.2337/diabetes.35.1.74

V

  1. Verspohl, E J

    • Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes January 1986 35:38-43; doi:10.2337/diabetes.35.1.38

  2. Voyles, N R

    • Opioid peptides in rat islets of Langerhans. Immunoreactive met- and leu-enkephalins and BAM-22P. Diabetes January 1986 35:52-57; doi:10.2337/diabetes.35.1.52

W

  1. Ward, G M

    • Structure of the human erythrocyte insulin receptor. Diabetes January 1986 35:101-105; doi:10.2337/diabetes.35.1.101

  2. Weaver, C

    • An immunohistochemical, ultrastructural, and physiologic study of pancreatic islets from copper-deficient, penicillamine-treated rats. Diabetes January 1986 35:13-19; doi:10.2337/diabetes.35.1.13

  3. Wells, M

    • Opioid peptides in rat islets of Langerhans. Immunoreactive met- and leu-enkephalins and BAM-22P. Diabetes January 1986 35:52-57; doi:10.2337/diabetes.35.1.52

  4. Williams, J A

    • Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes January 1986 35:38-43; doi:10.2337/diabetes.35.1.38

  5. Williamson, J R

    • Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes January 1986 35:20-27; doi:10.2337/diabetes.35.1.20

  6. Wilson, J M

    • The glucokinase glucose sensor in human pancreatic islet tissue. Diabetes January 1986 35:61-67; doi:10.2337/diabetes.35.1.61

Y

  1. Yki-Järvinen, H

    • Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII. Diabetes January 1986 35:78-82; doi:10.2337/diabetes.35.1.78

  2. Yoshimura, Y

    • New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells. Diabetes January 1986 35:74-77; doi:10.2337/diabetes.35.1.74

Z

  1. Zawadzki, J

    • Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes January 1986 35:1-5; doi:10.2337/diabetes.35.1.1

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement